News

Ticker News Interview

Name: Ticker News Interview
Uploaded: 2021-05-06T01:22:19+00:00
Channel: Haley Chartres
Description: Botanix Pharmaceutical’s (ASX:BOT) Executive Director, Matt Callahan, spoke with the Ticker News team yesterday to detail the next phase of our BTX 1801 antimicrobial program, which will target nasal decolonisation of Staph aureus in haemodialysis patients. https://youtu.be/0p2V44WgDE0

May 6, 2021/in Featured, Latest News, News, Videos /by Haley Chartres

Botanix Pharmaceutical’s (ASX:BOT) Executive Director, Matt Callahan, spoke with the Ticker News team yesterday to detail the next phase of our BTX 1801 antimicrobial program, which will target nasal decolonisation of Staph aureus in haemodialysis patients.